Inventor

KUFER PETER

DE65 patents

⚠️ This page may combine multiple inventors who share the name “KUFER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KUFER PETER

AMGEN RES MUNICH GMBH

Binding molecules for BCMA and CD3

Antibody constructs for DLL3 and CD3

Binding molecules for BCMA and CD3

BCMA and CD3 bispecific T cell engaging antibody constructs

Binding molecules for BCMA and CD3

Antibody constructs for EGFRVIII and CD3

Pharmaceutical compositions with resistance to soluble CEA

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

Antibody constructs for DLL3 and CD3

Binding molecules for BCMA and CD3

Binding molecules for BCMA and CD3

Antibody constructs for DLL3 and CD3

PSMA and CD3 bispecific T cell engaging antibody constructs

Dosage regimen for administering a CD19XCD3 bispecific antibody

Antibody constructs for CDH19 and CD3

Optimized cross-species specific bispecific single chain antibody contructs

Bispecific T cell engaging antibody constructs

Bispecific single chain antibodies with specificity for high molecular weight target antigens

Cross-species-specific PSMAxCD3 bispecific single chain antibody

BCMA and CD3 bispecific T cell engaging antibody constructs

Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3

Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains

Pharmaceutical compositions with resistance to soluble CEA

PPS for the prevention of potential adverse effects caused by CD3 specific binding domains

Antibody constructs for DLL3 and CD3

Antibody constructs for DLL3 and CD3

Cross-species-specific single domain bispecific single chain antibody

MICROMET AG

Bispecific antibodies

Means and methods for the treatment of tumorous diseases

Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders

Pharmaceutical composition comprising a bispecific antibody for EpCAM

CD 19×CD3 specific polypeptides and uses thereof

CD19xCD3 specific polypeptides and uses thereof

Human antibodies that bind human 17-A1/EpCAM tumor antigen

Method of identifying binding site domains that retain the capacity of binding to an epitope

Antibodies that bind human 17-A1/EpCAM tumor antigen

KUFER PETER

Human-anti-human cd3 binding molecules

Cross-species-specific PSMAxCD3 bispecific single chain antibody

Less immunogenic binding molecules

Cross-species-specific single domain bispecific single chain antibody

Bispecific single chain antibodies with specificity for high molecular weight target antigens

Pharmaceutical composition comprising a bispecific antibody for EpCAM

AMGEN INC

Antibody constructs for CDH19 and CD3

Binding molecules for BCMA and CD3

Antibody constructs for CDH19 and CD3

Binding molecules for BCMA and CD3

KISCHEL ROMAN

Composition comprising cross-species-specific antibodies and uses thereof

NAGORSEN DIRK

Dosage regimen for administering a CD19XCD3 bispecific antibody

LUTTERBUESE RALF

Pharmaceutical compositions with resistance to soluble CEA

BAEUERLE PATRICK

Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemia